| Active ingredient (INN) | Abiraterone |
|---|---|
| Brand names | Abiraterona Teva, Abiraterona Sandoz, Abiraterone Accord, Abiraterona Glenmark, TEVA abiraterone acetate |
| ATC level 5 | L02BX03 |
| ATC level 4 | L02BX |
| Therapeutic category | Auto-created by Agenzia Italiana del Farmaco — Carenze scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Sun Pharma ANZ Pty Ltd, Teva Pharma Australia Pty Ltd, HIKMA PHARMACEUTICALS USA INC., Janssen-Cilag Pty Ltd +3 more |
| Registrations on file | 14 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| YONSA MPRED abiraterone acetate | 125 mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| TEVA abiraterone acetate | 250 mg | — | 🇦🇺 AU | Teva Pharma Australia Pty Ltd | Active |
| TE-ABIRATERONE abiraterone acetate | 250 mg | — | 🇦🇺 AU | Teva Pharma Australia Pty Ltd | Active |
| TEVA abiraterone acetate | 500 mg | — | 🇦🇺 AU | Teva Pharma Australia Pty Ltd | Active |
| TE-ABIRATERONE abiraterone acetate | 500 mg | — | 🇦🇺 AU | Teva Pharma Australia Pty Ltd | Active |
| Abiraterone | 250mg/1 | tablet | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| ZYTIGA abiraterone acetate | 250 mg | — | 🇦🇺 AU | Janssen-Cilag Pty Ltd | Active |
| JANSSEN ABIRATERONE abiraterone acetate | 250 mg | — | 🇦🇺 AU | Janssen-Cilag Pty Ltd | Active |
| ZYTIGA abiraterone acetate | 500 mg | — | 🇦🇺 AU | Janssen-Cilag Pty Ltd | Active |
| JANSSEN ABIRATERONE abiraterone acetate | 500 mg | — | 🇦🇺 AU | Janssen-Cilag Pty Ltd | Active |
| Abiraterone Acetate | 250mg/1 | tablet | 🇺🇸 US | Mylan Pharmaceuticals Inc. | Active |
| Abiraterone Acetate | 500mg/1 | tablet | 🇺🇸 US | Mylan Pharmaceuticals Inc. | Active |
| Abiraterone Acetate | 125mg/1 | tablet | 🇺🇸 US | Golden State Medical Supply, Inc. | Active |
| Abiraterone | 500mg/1 | tablet | 🇺🇸 US | BluePoint Laboratories | Active |